Topics

Sterling Pharma to invest $1.5m in US facility expansion

05:37 EDT 29 Oct 2019 | Manufacturing Chemist

The UK-based global CDMO plans to expand the cGMP production suites, add a non-GMP scale-up production facility, expand its QC lab and increase the North Carolina site’s R&D capacity

Original Article: Sterling Pharma to invest $1.5m in US facility expansion

NEXT ARTICLE

More From BioPortfolio on "Sterling Pharma to invest $1.5m in US facility expansion"

Quick Search